Company Overview of Galera Therapeutics, Inc.
Galera Therapeutics, Inc., a clinical-stage biotechnology company, develops drugs targeting oxygen metabolic pathways. The company primarily focuses on the prevention of radiation-induced toxicity, including mucositis, and the treatment of cancer. Its small molecule dismutase mimetics mimics the activity of the human superoxide dismutase enzymes. The company was founded in 2009 and is based in Malvern, Pennsylvania.
2 West Liberty Boulevard
Malvern, PA 19355
Founded in 2009
Key Executives for Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|BioDisplay Technologies, Inc.||United States|
|International Immuno Diagnostics Inc.||United States|
|Endogeny Bio Corporation||United States|
|Hemera Biosciences Inc.||United States|
|AFG Biosolutions, Inc.||United States|
Recent Private Companies Transactions
October 1, 2015
To contact Galera Therapeutics, Inc., please visit www.galeratx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.